tiprankstipranks
Advertisement
Advertisement

AU:COV Stock Latest News

Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
Company AnnouncementsCleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
3d ago
COV
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
PremiumCompany Announcements
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
4d ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
PremiumCompany Announcements
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
1M ago
COV
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
PremiumCompany Announcements
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
1M ago
COV
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
PremiumCompany Announcements
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
2M ago
COV
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
PremiumCompany AnnouncementsCleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
3M ago
COV
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
Premium
Company Announcements
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
4M ago
COV
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
Premium
Company Announcements
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
4M ago
COV
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
PremiumCompany Announcements
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
4M ago
COV
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
PremiumCompany Announcements
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
4M ago
COV
CLEO Diagnostics Seeks ASX Quotation for Additional Ordinary Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks ASX Quotation for Additional Ordinary Shares
4M ago
COV
CLEO Diagnostics Seeks ASX Quotation for 8.3 Million New Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks ASX Quotation for 8.3 Million New Shares
4M ago
COV
CLEO Diagnostics Ltd Announces Proposed Securities Issuance
PremiumCompany AnnouncementsCLEO Diagnostics Ltd Announces Proposed Securities Issuance
5M ago
COV
Cleo Diagnostics Secures $5M for U.S. Launch and Screening Development
Premium
Company Announcements
Cleo Diagnostics Secures $5M for U.S. Launch and Screening Development
5M ago
COV
Cleo Diagnostics Ltd Initiates Trading Halt Ahead of Major Announcement
Premium
Company Announcements
Cleo Diagnostics Ltd Initiates Trading Halt Ahead of Major Announcement
5M ago
COV
Cleo Diagnostics Secures $1.7M R&D Refund, Strengthening Financial Position for U.S. Market Entry
PremiumCompany Announcements
Cleo Diagnostics Secures $1.7M R&D Refund, Strengthening Financial Position for U.S. Market Entry
5M ago
COV
Cleo Diagnostics Ltd Reports Successful AGM Outcomes
PremiumCompany Announcements
Cleo Diagnostics Ltd Reports Successful AGM Outcomes
5M ago
COV
Cleo Diagnostics Appoints Key Opinion Leader for U.S. Market Entry
PremiumCompany Announcements
Cleo Diagnostics Appoints Key Opinion Leader for U.S. Market Entry
5M ago
COV
Cleo Diagnostics Expands U.S. Market Potential for Ovarian Cancer Test
PremiumCompany Announcements
Cleo Diagnostics Expands U.S. Market Potential for Ovarian Cancer Test
6M ago
COV
Cleo Diagnostics Advances Towards U.S. Market with FDA Engagement and Biobank Acquisitions
PremiumCompany AnnouncementsCleo Diagnostics Advances Towards U.S. Market with FDA Engagement and Biobank Acquisitions
6M ago
COV
Cleo Diagnostics Advances Towards Global Market with Successful MDSAP Audit
Premium
Company Announcements
Cleo Diagnostics Advances Towards Global Market with Successful MDSAP Audit
6M ago
COV
Cleo Diagnostics Ltd Announces 2025 Annual General Meeting
Premium
Company Announcements
Cleo Diagnostics Ltd Announces 2025 Annual General Meeting
7M ago
COV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >